Shofu, Inc. engages in the manufacture and sale of dental materials and equipment. It operates through the following segments: Dental, Nail, and Others. The Dental segment deals with the manufacture and sale of dental related materials and equipment, and repair services. The Nail segment handles the manufacture and sale of nail care tools and equipment products, cosmetics, and services. The Others segment includes the manufacture and sale of industrial materials and devices. The company was founded by Kajo Shofu III on May 15, 1922 and is headquartered in Kyoto, Japan.

Align Technology, Inc. designs, manufactures, and markets the invisalign system for treating malocclusion or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. The company's products include Invisalign Full for the treatment of a range of malocclusions; Invisalign Express, a solution for less complex orthodontic cases; Invisalign Teen, which is designed to meet the specific needs of the non-adult comprehensive or teen treatment market; Vivera retainers that offer aesthetic retention solution for invisalign and non-invisalign patients; and Invisalign Assist, which is designed for general practitioners for selecting, monitoring, and finishing invisalign cases. It also offers ancillary products comprising cleaning material and adjusting tools for dental professionals. Align Technology distributes its products directly to orthodontists and general practitioner dentists in North America, Europe, the Asia Pacific, Latin America, and Japan. The company was founded in 1997 and is headquartered in Santa Clara, California.

Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.

Pharnext is an advanced clinical-stage biopharmaceutical company founded in April 2007 by renowned scientists and entrepreneurs including Professor Daniel Cohen and collaborators, pioneers in modern genomics. The company develops new therapeutics for neurodegenerative diseases - orphan and common – where there are currently no cures and existing therapies available. Pharnext is the pioneer of a new paradigm for the discovery of medicinal drugs: PLEOTHERAPY™. The R&D approach protected by Pharnext systemizes new uses of approved drugs. It is based on network pharmacology utilizing complex and extensive genomic data to identify the thousands of molecules possibly involved in a disease. From this disease molecular network, Pharnext deduces synergistic combinations of drugs already approved but for unrelated indications. These novel therapeutics called PLEODRUG™ are then developed at new optimal doses and under new formulations. They offer several key advantages: efficacy, safety, and intellectual property including several composition of matter patents already granted. The proof of concept of the PLEOTHERAPY approach was obtained with PLEODRUG PXT3003 in Charcot-Marie-Tooth disease type 1A (CMT1A) through positive and consistent Phase 2 and Phase 3 results. PLEODRUG PXT864 generated encouraging Phase 2 data in Alzheimer’s disease. They also plan to develop the same agent in other orphan and common neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis (ALS).

Lion Corp. engages in the manufacture and sale of dental and body care, laundry, household cleaners, pharmaceuticals, and health products. It operates through the following business segments: Consumer Products, Industrial Products, Overseas, and Other. The Consumer Products segment manufactures and sells daily necessities, over-the-counter drugs and function food. These include toothpaste, toothbrush, hand soap, antipyretic analgesic, eye drops, nutritional drink, laundry detergent, softener, and bleach. The Industrial Products segment provides chemical raw materials and business supplies. These include oil and fat activator, conductive carbon, and professional cleaning agent. The Overseas segment handles the operation of overseas subsidiaries that manufactures and sells daily commodities. The Other segment includes construction contracting, real estate management, transportation storage, and staffing. The company was founded by Tomijiro Kobayashi on October 30, 1891 and is headquartered in Tokyo, Japan.

Feagle Co., Ltd. is engaged in providing investment services. It offers financial investment activities. The company was founded by Kim, Gyu-Cheon on November 4, 2014 and is headquartered in Yangsan, South Korea.

Yujun Electronic Gifts (Shenzhen) Co., Ltd., established on 2005-02-28, Business scope includes general business items:New material technology promotion service;New material technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;General merchandise sales;electronics sales;Sales of plastic products;Rubber Products Sales;Chemical product sales(No licensed chemical products);Metal Material Sales;Metal Products Sales;Wearable smart device sales;Smart Instrument Sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:Production and operation of electronic plastic toys,Plastic Hardware Jewelry,plastic product,ballpoint pen,toothbrush,mold;Wholesale of the above products and hand sanitizer,Import and export and related supporting business(Commodities that do not involve state trade management,Quota involved,Commodities managed by license management and other special regulations,Apply in accordance with relevant national regulations).Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Chengdu Lvdi Technology Co., Ltd., established on 2011-07-15, Business scope includes medical research and experimental development;Educational Consulting(Excluding study abroad consulting and intermediary services);Intellectual Property Services;Trademark agency;Business Registration Agent.(The above business scope does not include national laws,Administrative regulations,Items prohibited or restricted by the State Council,Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Shantou Honglong Industrial Co., Ltd., established on 2007-04-29, The business scope includes the production of cosmetics;Production,processing,Sales:toothbrush,oral hygiene products,shoe,cap,EVAshoe material,comb,cup,bag,soap,plastic products,Hotel Supplies,clothing,Non-woven products,synthetic detergent;Medical device management;Sales and Online Sales:Face mask,disinfection products(Excluding hazardous chemicals),toothpaste,razor,Daily necessities,cosmetic,arts and crafts(ivory,Except rhino horn and its products),electronic product,bed linings,Stationery,holiday necessities,Chemical raw materials and products;goods,Technology Import and Export(law,Except for items prohibited by administrative regulations;law,Projects restricted by administrative regulations must be licensed before they can be operated).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Handan Hongsite Dental Teaching Aids Co., Ltd., established on 2008-05-19, The scope of business includes the research and development and production of dental and related medical teaching models;Stomatology and related medical teaching and experimental consumables production;Import and export business;Sales and maintenance of Class I medical devices;Cosmetic sales**(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nanjing Oxal Gear Co., Ltd., established on 2006-09-05, The scope of business includes two types of6863Production of dental materials,Sales(Subject to the medical device production license);Dental medical equipment sales;Technology development in dental technology,technical consulting,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Centro de Investigación Biomédica en Red provides research and development of bioengineering, biomaterials, and nanomedicine networks.

Apexum Ltd. develops and commercializes a family of miniature, minimally invasive dental surgical tools, facilitating highly innovative methods for the treatment of Periapical Lesions, associated with root canal infections.\nApexum develops dental surgical tools for intra-osseous surgery. Its products are used in milling, grinding, dissecting, suction, and injecting procedures.

Acceleron Pharma, Inc. operates as a biopharmaceutical company. The company engages in developing, manufacturing, and commercializing novel biotherapeutics that modulate the growth of bone, muscle, fat, and the vasculature to treat musculoskeletal, metabolic, and cancer-related diseases. Its products include ACE-011 Program, a novel bone forming agent that helps to treat cancer-related bone loss; ACE-031 Program that helps to treat diseases involving the loss of muscle mass, strength, and function in diseases, including muscular dystrophy, amyotrophic lateral sclerosis, and cancer-related muscle loss; and ACE-041, a protein therapeutic that binds a member of the growth and differentiation factor family necessary for angiogenesis. It develops therapies based on growth and differentiation factors that regulate the cellular proliferation, differentiation, and survival of a range of tissue types. The company offers treatments for cancer-related bone loss, cancer-related muscle loss, neuromuscular diseases, and metabolic disorders. Acceleron Pharma, Inc. was founded in 2003 and is headquartered in Cambridge, Massachusetts.

Servier are driven by the belief in the excellence of their profession. Theirs is a research-based organization, fulfilling a basic need and dedicated to the future.

Unilever NV engages in the production and marketing of consumer goods in the nutrition, hygiene, and personal care categories. It operates through the following segments: Beauty and Personal Care, Foods and Refreshment, and Home Care. The Beauty and Personal Care segment covers the sales of skin and hair care products, deodorants and oral care products. The Foods and Refreshment segment includes the sales of soups, bouillons, sauces, snacks, mayonnaise, salad dressings, margarines and spreads. The Home Care segment is in charge of the sales of home care products such as powders, liquids and capsules, soap bars, and a wide range of cleaning products. The company was founded on November 9, 1927 and is headquartered in Rotterdam, Netherlands.

Merz Pharma GmbH & Co. KGaA is an innovative and international healthcare company with its own research and development department. It focuses on drugs for the treatment of illness in the fields of neurology and psychiatry. The company is bundling the activities of its subsidiaries Merz Pharmaceuticals, Merz Consumer Care, Merz Dental, and Merz Hygiene, with products ranging from prescription drugs and OTC products for health and wellness, materials for dentists and dental technicians to hygienic products for medical disinfection and cleaning.\nThe units of Merz Group Services, the fith Merz subsidiary, include Human Resources, Supply Chain/Purchasing, Information Technology (IT), Technical Operations and Finances/Controlling.

American Cyanamid Company was a U.S.-based diversified company with businesses in several fields. The company was a manufacturer of agricultural chemicals, cosmetics, perfumes, building products, plastics and pharmaceuticals. The company was listed as a top 100 manufacturing company by Fortune magazine in the 1970s. Cyanamid was founded in 1907 and employed over 100,000 people around the world by 2000. The company maintained a monopoly over tetracycline, an antibiotic used against bacterial infections. A theft of the organism led to the loss of the monopoly as rival companies were able to produce generic versions of the formula, leading to huge losses to the company. The company sold most of its businesses in the early 2000s and is now operated under the name Cytec.